Pharmaceutical Manufacturing Archives - Page 5 of 5 - Executive Platforms: Thought Leader Series

The Things We Can Achieve and Our Shared Journey Along the Way

April 8, 2022

How the pandemic has impacted innovation, technology, people and our ways of working and thinking Understanding current capabilities and where we need to be collectively headed as a community of pharmaceutical manufacturers Strategies that compel and empower us to move beyond past constraints and set new, ambitious goals for the future Thinking beyond the data to find purpose and meaningful connections for people — Arleen Paulino SVP Global Manufacturing Amgen Arleen Paulino, Senior Vice President, Manufacturing, leads Amgen’s commercial manufacturing organization. Prior to this role, Paulino served as vice president, Site Operations at Amgen Singapore Manufacturing from 2016 to 2018,…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

What Lessons Should Pharmaceutical Manufacturers Take Away from Operation Warp Speed?

April 8, 2022

Offering an overview of the public-private partnership that facilitated and accelerated the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics During the pandemic our industry faced crisis and achieved the seemingly impossible. What drives an extraordinary performance? Building stronger bonds of communication, collaboration, and coordination between industry partners and regulators to serve patients better Discussing which parts of our experience with Operation Warp Speed can be built into our industry’s long-term future — Carlo de Notaristefani Lead, Manufacturing & Supply Chain Advisor Operation Warp Speed An international operations executive with global technical, operational, and P&L experience, Carlo has…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Chair’s Welcome Address and PMWS21 Opening Keynote – A Look into the Future: How Pharmaceutical Manufacturing Is Transforming to Bring Hope to Patients

May 19, 2021

Highlighting what should the industry do differently to achieve an ambitious future where all patients can receive lifesaving medicines safely, swiftly, reliably and affordably Exploring how and where products will be made, and how those products will be delivered by adopting system-driven planning and automation capabilities, leveraging the power of data and advanced analytics Describing a patient-centric pipeline the industry needs in order to deliver transformative therapies for all humanity A glimpse of how the world will evolve as molecular complexity increases in the future for small molecules, blurring the boundaries between small and large molecules — Sanat Chattopadhyay EVP…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Day Two Chair’s Opening Remarks and Keynote: The Vertex Story: Serial Innovation in Manufacturing

May 19, 2021

Sharing Vertex’s track record for serial innovation in manufacturing to create transformative medicines for people with serious diseases and high unmet medical needs Highlighting Vertex’s success with small molecule continuous manufacturing in Cystic Fibrosis Transforming manufacturing in cell and genetic therapies for Sickle Cell Disease, Beta Thalassemia, and Type 1 Diabetes — E. Morrey Atkinson SVP and Head of Commercial Manufacturing and Supply Chain Vertex Pharmaceuticals As SVP and Head of Commercial Manufacturing & Supply Chain, Morrey’s current responsibilities include defining the commercial manufacturing and supply chain strategy needs, as well as, designing and building a global organization and supply…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Leading Global Supplies in Times of High Biologic Demands Now and After the Pandemic Crisis

May 19, 2021

Strong wave of innovation and new Biologic therapies resulting in high demands Building flexible global capacities at various scales and multiple global locations to ensure reliable supplies and serve patients’ needs worldwide Business continuity planning, crisis management, pandemic preparedness & implementation of additional specific protection measures Close collaboration, intensive and solution-oriented exchange with customers and partners to ensure global patient supplies Managing diverse and complex challenges through digital transformation Critical success factor: Operational excellence, capacity & capabilities expansion and our peoples dedication — Uwe Buecheler Corporate SVP Biopharmaceuticals Boehringer Ingelheim Uwe Buecheler, Ph. D. joint Boehringer Ingelheim (formerly Dr. Karl…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Rethinking our Supply Chain to be Patient-Centric

May 19, 2021

Challenges biotech companies are facing as patients expectations are increasing Ensuring the end-to-end supply chain can respond in the face of fierce competition for innovation Leveraging data and analytics to increase value and service to patients Keeping patients central as external factors accelerate need for resiliency — Kimberly Lounds Foster SVP Global Supply Chain Bristol-Myers Squibb Kimberly Lounds Foster is Senior Vice President, Global Supply Chain at Bristol-Myers Squibb, where she oversees the clinical and commercial supply chain. Bristol develops and manufactures products on multiple technology platforms, including small molecules, biologics and cell therapies. Kimberly joined Bristol through the Celgene…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Reducing Drug Shortages… and High Prices

May 19, 2021

How hospital systems and philanthropies came together to establish their own supply chain for essential quality generic medicines Living the mission to make quality generic medicines accessible and affordable to everyone Improving the resiliency of the supply of essential medicines used in hospitals, often for critical care, day-to-day and during a pandemic Ensuring a safe and stable supply of essential medicines for U.S. patients — Donna Gulbinski Chief Quality & Regulatory Affairs Officer Civica Rx Donna’s expertise spans worldwide operations, quality, and regulatory experience across vaccine, biological, pharmaceutical and device technologies where she was an operational leader with a history…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Keynote: Delivering Excellence While Navigating Transition

May 19, 2021

Highlighting how operations and manufacturing can think differently to pivot for crises and global events Preparing for M&A opportunities and adapting for a changing business model Discussing the importance of equity, leadership and people as catalysts of culture and change within the industry as we work to serve patients better — Azita Saleki-Gerhardt EVP, Operations Abbvie Dr. Azita Saleki-Gerhardt is Executive Vice President, Operations, at AbbVie, leading a team of scientific, engineering, business, quality, supply chain, security, purchasing and manufacturing professionals responsible for supply and distribution of all AbbVie products, as well as a number of corporate services. Dr. Saleki-Gerhardt…

WHITEPAPER, White Paper, LIFE SCIENCES

Why Executive Platforms Decided to Launch Pharma Manufacturing World as Our Seventh Summit Series

July 17, 2019

An Open Letter by Geoff Micks Head of Content & Research Executive Platforms Those of you who follow us on Twitter or LinkedIn may have already seen the ‘Save the Date’ announcement for Executive Platforms’ newest summit series, Pharma Manufacturing World Summit. The first edition of which will run June 22nd and 23rd, 2020, at the Boston Marriott Copley Place. We are very excited about it, as you can imagine. Or maybe you cannot? It occurs to me that with each of the last six series Executive Platforms has launched, we never made a public announcement explaining our thinking…

Pharmaceutical Manufacturing

The Things We Can Achieve and Our Shared Journey Along the Way

What Lessons Should Pharmaceutical Manufacturers Take Away from Operation Warp Speed?

Chair’s Welcome Address and PMWS21 Opening Keynote – A Look into the Future: How Pharmaceutical Manufacturing Is Transforming to Bring Hope to Patients

Day Two Chair’s Opening Remarks and Keynote: The Vertex Story: Serial Innovation in Manufacturing

Leading Global Supplies in Times of High Biologic Demands Now and After the Pandemic Crisis

Rethinking our Supply Chain to be Patient-Centric

Reducing Drug Shortages… and High Prices

Keynote: Delivering Excellence While Navigating Transition

Why Executive Platforms Decided to Launch Pharma Manufacturing World as Our Seventh Summit Series

NASCES

NAFS

NAFMS

EUSCES

BMWS

NALES

MDMES

NAFES

NASRS

NAHRES

NAMES

PMWS

NAISS

Categories

Newsletter